Overview

Phase II Study of HMPL-004 in Patients With Ulcerative Colitis

Status:
Completed
Trial end date:
2009-10-13
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the safety and efficacy of HMPL-004 in patients with active mild to moderate ulcerative colitis (UC), compared with placebo.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hutchison Medipharma Limited
Criteria
Inclusion Criteria:

- Have active confirmed mild to moderate ulcerative colitis

Exclusion Criteria:

- Diagnosed with Crohn's Disease or